Susan Garfield
Overview
Explore the profile of Susan Garfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garfield S, White A, Garfield F, Siegrist R, Eslami N
Front Health Serv
. 2024 Jan;
3:1297266.
PMID: 38164390
No abstract available.
2.
Garfield S, Almeida R, Donaldson K, Eslami N
Front Health Serv
. 2023 Aug;
3:1187229.
PMID: 37560196
As the world suffered through the COVID-19 pandemic, it is increasingly clear that the health of populations is foundational to a high-functioning economy, corporate well-being, and a core driver of...
3.
Edouard V, Foley M, Gordon A, Garfield S, Dincer L, Nelson K
Front Public Health
. 2023 Jul;
11:1176198.
PMID: 37521982
No abstract available.
4.
Garfield S, Polisena J, Spinner D, Postulka A, Lu C, Tiwana S, et al.
Value Health
. 2016 Aug;
19(5):577-87.
PMID: 27565275
Background: Health technology assessments (HTAs) are increasingly used to inform coverage, access, and utilization of medical technologies including molecular diagnostics (MDx). Although MDx are used to screen patients and inform...
5.
Wright T, Huang J, Baker E, Garfield S, Hertz D, Cox J
Am J Manag Care
. 2016 Mar;
22(3):e95-105.
PMID: 26978241
Objectives: This study assessed the clinical and budgetary impacts of human papillomavirus (HPV) primary screening with HPV16/18 genotyping, in contrast to current cervical cancer screening strategies. Study Design: A decision-tree...
6.
Tang B, Raviv A, Esposito D, Flanders K, Daniel C, Nghiem B, et al.
Stem Cell Reports
. 2014 Dec;
4(1):155-169.
PMID: 25497455
Many tumors are hierarchically organized with a minority cell population that has stem-like properties and enhanced ability to initiate tumorigenesis and drive therapeutic relapse. These cancer stem cells (CSCs) are...
7.
Amorosi S, Armstrong S, Deppo L, Garfield S, Stein K
Europace
. 2014 Apr;
16(8):1131-6.
PMID: 24687964
Aims: Major practice changes require both clinical and economic rationale, especially where a novel device replaces an established pharmaceutical therapy. Recent studies have reported the clinical benefits of percutaneous left...
8.
Pandey G, Yanover C, Miller-Jenkins L, Garfield S, Cole S, Curran J, et al.
Nat Med
. 2013 Sep;
19(10):1318-24.
PMID: 24037092
Neutralizing antibodies (inhibitors) to replacement factor VIII (FVIII, either plasma derived or recombinant) impair the effective management of hemophilia A. Individuals with hemophilia A due to major deletions of the...
9.
Weng M, Lee J, Wei S, Li Q, Shahamatdar S, Hsu D, et al.
Proc Natl Acad Sci U S A
. 2012 Dec;
109(52):E3659-67.
PMID: 23236152
Cancers with Ras mutations represent a major therapeutic problem. Recent RNAi screens have uncovered multiple nononcogene addiction pathways that are necessary for the survival of Ras mutant cells. Here, we...
10.
Motegi S, Garfield S, Feng X, Sardy M, Udey M
Arterioscler Thromb Vasc Biol
. 2011 Aug;
31(11):2653-64.
PMID: 21868707
Objective: Pericytes/pericyte precursors produce milk fat globule-associated protein with epidermal growth factor and factor VIII-like domains (MFG-E8) in vivo, and this α(v) integrin ligand enhances angiogenesis in tumors and in...